Introducing FIT-Detect+™

Polymedco's next-generation manual fecal immunochemical test is designed to simplify colorectal cancer screening without compromising performance.

FIT-Detect+™ is now available as the replacement for OC-Light S® FIT. Built for flexibility across healthcare settings, from physician offices and labs to at-home use, FIT-Detect+ delivers reliable immunochemical detection with a simplified implementation footprint and minimal disruption to existing screening programs.

Have questions about FIT-Detect+™?

What is FIT-Detect+™?


FIT-Detect+™ is a rapid, qualitative fecal immunochemical test (FIT) that detects human hemoglobin in stool samples, providing an important early indicator of gastrointestinal conditions including colorectal cancer, polyps, colitis, and diverticulitis. Using solid-phase chromatographic immunoassay technology, FIT-Detect+ is specific to human hemoglobin and unaffected by animal hemoglobin from food sources, eliminating the need for dietary restrictions before testing. Recommended annually by the American Cancer Society for average-risk adults age 45 and older, FIT-Detect+ is designed for use across a wide range of healthcare settings, including physician offices, clinical labs, and direct-to-patient programs.1

Important Transition Notice

OC-Light S® FIT will be discontinued and FIT-Detect+™ is the designated successor. Polymedco is committed to a seamless transition; contact your representative to begin planning today.

key features

Built for Simplicity. Designed for Performance.


Single-sample collection

One sample is all it takes, reducing patient burden and simplifying program logistics.

No analyzer required

FIT-Detect+ is a lateral flow immunochemical test. No specialized instrumentation or laboratory analyzer needed.

Easy-to-use cassette format

Clear positive/negative result interpretation in 5–10 minutes, suitable for professional testing or patient self-collection.

At-home screening option

Supports direct-to-patient distribution models, helping extend screening reach beyond the clinical setting and improve program participation rates.

No dietary or medication restrictions

Patients do not need to modify their diet or pause medications before testing, removing a common barrier to compliance.

Cost-effective screening solution

Analyzer-free workflow and simplified collection process support efficient, scalable implementation across healthcare settings.

Validation Data

Current validation data demonstrate2:

Disclaimer

Current data reflects analytical validation studies. Results are not conclusive evidence of the presence or absence of gastrointestinal disease. Any positive result should be followed up with further clinical examination.

Frequently Asked Questions


What is FIT-Detect+™?

FIT-Detect+ is a manual fecal immunochemical test (FIT) designed to detect hidden blood (humanhemoglobin) in stool samples as an aid in identifying gastrointestinal disorders, including colorectal cancer.

FIT-Detect+ was selected to provide a simpler patient experience while maintaining strong clinical performance and supporting cost-effective colorectal cancer screening programs.

No. FIT-Detect+ is a simple lateral flow immunochemical test that does not require an analyzer or specialized instrumentation.

Yes. FIT-Detect+™ supports at-home sample collection, making it well-suited for direct mail and direct-to-patient distribution programs. The personal use kit is a complete, self-contained collection package. Samples are stable at room temperature for up to 10 days, providing flexibility for return logistics.

FIT-Detect+™ uses a single-sample collection process, reducing patient burden and simplifying the overall screening workflow.

No. Patients do not need to modify their diet or discontinue medications prior to testing. FIT-Detect+ is specific to human hemoglobin and does not cross-react with animal hemoglobin from common food sources.

FIT-Detect+™ offers reliable FIT screening performance with the added benefit of an improved cassette format, single-sample collection, and the option for at-home patient use. Polymedco will provide detailed transition support to help your organization maintain continuity in the screening program.

Most organizations should experience minimal disruption during the transition. Because FIT-Detect+ does not require an analyzer, labs and physician offices that relied on OC-Light S for strip-based FIT will find the workflows compatible. Polymedco will work closely with your team to support implementation, training, and ordering logistics.

Yes. FIT-Detect+ will have new product SKUs and ordering information that will replace the current OC-Light S SKUs. Polymedco will provide detailed guides and ordering resources to help customers identify the appropriate replacement products and ensure an easy transition.

We encourage customers to begin planning now. OC-Light S® FIT will be discontinued effective September 2026, with the transition period spanning Q3 and early Q4 2026. Beginning the conversation early ensures the smoothest possible changeover for your program and patients.

Yes. Polymedco will provide educational materials, implementation guidance, and hands-on support resources throughout the transition. Your Polymedco representative is your primary point of contact for transition planning.

Polymedco is committed to making this process as smooth as possible for customers. Pricing for FIT-Detect+ is expected to remain comparable to current OC-Light S pricing.

Yes. The analyzer-free workflow, simplified patient collection process, and single-sample design are intended to support cost-effective implementation across a range of healthcare settings, from large health systems to independent physician offices.

Ready to Transition?

From evaluating implementation timelines to aligning ordering and training with your program's operational needs, our team is here to support your move to FIT-Detect+™.

Contact your Polymedco representative or reach us at customer_service@polymedco.com.